Should the initial drug used to treat osteoarthritis pain be a nonsteroidal antiinflammatory drug?

Journal of Rheumatology

Volumn 28, Issue 3, 2001, Pages 467-473

  Brandt, K D ^a   Bradley, J D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

CLINICAL PROTOCOL; DIGESTIVE SYSTEM PERFORATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFLAMMATION; OSTEOARTHRITIS; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; OSTEOARTHRITIS; PAIN;

EID: 0035093682     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (52)

1. Guidelines for the medical management of osteoarthritis: I. Osteoarthritis of the hip
2. Guidelines for the medical management of osteoarthritis: II. Osteoarthritis of the knee
3. Recommendations for the medical management of osteoarthritis of the hip and knee
4. North of England Evidence Based Guideline Development Project: Summary guideline for nonsteroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis
5. EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials
6. Osteoarthritis
7. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
8. Factors influencing publication of research results: Follow-up of applications submitted to two institutional review boards
9. Publication bias in clinical research
10. Evaluation of acetaminophen in the management of osteoarthritis of the knee
11. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients. A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
12. Comparison of WOMAC scores in osteoarthritis patients in the ACTA [Arthrotec (Diclofenac/Misoprostol) compared to acetaminophen] clinical trial
13. Comparison of quality of life assessments in osteoarthritis patients in the ACTA [arthrotec (diclofenac/misoprostol) compared to acetaminophen] clinical trial
14. Arthrotec compared to acetaminophen (ACTA): A clinical trial in patients with osteoarthritis (OA) of the hip or knee
15. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee
16. Treatment of knee osteoarthritis: Relationship of clinical features of joint inflammation to the response to a nonsteroidal anti-inflammatory drug or pure analgesic
17. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response
18. Ibuprofen versus buffered phenylbutazone in the treatment of osteoarthritis: Double-blind trial
19. Short-term treatment of osteoarthritis: A comparison of sodium meclofenamate and ibuprofen
20. A comparison of nefopam and flurbiprofen in the treatment of osteoarthritis
21. Severity of knee pain does not predict a better response to an anti-inflammatory dose of ibuprofen than to analgesic therapy in patients with osteoarthritis
22. Ibuprofen, acetaminophen and placebo in osteoarthritis of the knee: A six-day double-blind study
23. Single dose ibuprofen and diclofenac for postoperative pain
24. Preliminary study of the safety and efficacy of SC-58365, a novel cyclooxygenase 2 inhibitor
25. Efficacy, tolerability, and safety of celecoxib, a specific COX-2 inhibitor
26. Celecoxib for arthritis
27. MK-0966, a specific COX-2 inhibitor, has clinical efficacy comparable to diclofenac in the treatment of knee and hip osteoarthritis in a 26-week controlled clinical trial
28. MK-0966, a specific COX-2 inhibitor, has clinical efficacy comparable to ibuprofen in the treatment of knee and hip osteoarthritis in a 6-week controlled clinical trial
29. A comparative study of benoxaprofen and ibuprofen in osteoarthritis in general practice
30. Double-blind comparison of fenoprofen calcium and ibuprofen in osteoarthritis of large joints
31. Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis
32. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee
33. The PAIN study: Paracetamol, aspirin and ibuprofen new tolerability study. A large-scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia
34. A clinical trial comparing rofecoxib to celecoxib and acetaminophen in the treatment of osteoarthritis: Early efficacy results
35. COX-2 Inhibitors
36. Gastrointestinal toxicity and celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis
37. Renal and related cardiovascular effects of conventional and COX-2 specific NSAIDs and non-NSAID analgesics
38. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics
39. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
40. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis
41. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind placebo-controlled trial
42. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs
43. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs
44. COX-1-sparing NSAIDs - Is the enthusiasm justified?
45. Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis
46. Effects of self-care education on the health status of inner-city patients with osteoarthritis of the knee
47. Patient education interventions in osteoarthritis and rheumatoid arthritis: A meta-analytic comparison with nonsteroidal anti-inflammatory drug treatment
48. Reduction of joint pain in patients with knee osteoarthritis who have received monthly telephone calls from lay personnel and whose medical treatment regimens have remained stable
49. Lower body osteoarticular pain and dose of analgesic medications in older disabled women: The Women's Health and Aging Study